NASDAQ
ABVC BioPharma, Inc. (ABVC) has a free cash flow growth of 36.98% as of Friday, May 29, 2026. This represents a 115.49% increase compared to its 12-month average of -238.70%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.